US Stock MarketDetailed Quotes

MXCT MaxCyte

Watchlist
  • 3.100
  • -0.050-1.59%
Close Mar 25 16:00 ET
  • 3.030
  • -0.070-2.26%
Pre 04:40 ET
328.69MMarket Cap-7.95P/E (TTM)

MaxCyte Key Stats

MaxCyte Q4 2024 Earnings Date

Currency:USDMar 11, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
7.91M
8.69M
+784.00K
Beat Est.
-49.51%
-44.51%
+9.91%
EPS
-0.12
-0.10
+0.02
Beat Est.
-150.30%
-100.00%
+19.94%
Strong Buy

Mar 12, 2025

MaxCyte Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 9.770M--
--2025/Q1-- / 9.051M--
Mar 11, 20252024/Q48.693M / 7.909M--
Nov 6, 20242024/Q38.164M / 7.364M--
Aug 6, 20242024/Q210.429M / 7.933M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 9.770M--
--2025/Q1-- / 9.051M--
Mar 11, 20252024/Q48.693M / 7.909M--
Nov 6, 20242024/Q38.164M / 7.364M--
Aug 6, 20242024/Q210.429M / 7.933M--

Unlock Free Earnings Estimates

MaxCyte Earnings Reports

Read more

Market Insights

Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More